as on September 17, 2025 at 1:29 am IST
Day's Low
Day's High
4.53%
Downside
0.91%
Upside
52 Week's Low
52 Week's High
68.28%
Downside
19.94%
Upside
Check Adc Therapeutics Sa market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$372.4M
EPS (TTM)
-1.5333
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0EBITDA
-126.1M
Revenue (TTM)
77.2M
Profit Margin
-220.00%
Return On Equity TTM
0.00%
Compare market cap, revenue, PE, and other key metrics of Adc Therapeutics Sa with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $372.4M | -92.47% | NA | -220.00% | |
BUY | $61.1B | 251.26% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $101.2B | 47.46% | 28.09 | 31.86% | |
BUY | $59.6B | 0.6% | 14.1 | 31.37% |
The Adc Therapeutics Sa stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Adc Therapeutics Sa investment value today
Current value as on today
₹1,12,335
Returns
₹12,335
(+12.33%)
Returns from Adc Therapeutics Sa Stock
₹7,468 (+7.47%)
Dollar Returns*
₹4,867 (+4.87%)
Based on 12 analysts
83.33%
Buy
16.67%
Hold
0.00%
Sell
Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for Adc Therapeutics Sa. Average target price of $8.2
Get share price movements and forecasts by analysts on Adc Therapeutics Sa.
What analysts predicted
59.63%UPSIDE
Target Price
$8.2
Current Price
$3.31
Analyzed by
12 Analysts
Target
$8.20
Adc Therapeutics Sa target price $8.2, a slight upside of 59.63% compared to current price of $3.31. According to 12 analysts rating.
Search interest for Adc Therapeutics Sa Stock has decreased by -29% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 6 months, ADCT stock has moved up by 78.8%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 150.5%
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.2% return, outperforming this stock by 65.6%
Revenue Fall
Revenue is down for the last 2 quarters, 23.03M → 18.83M (in $), with an average decrease of 18.2% per quarter
Profit Down
Netprofit is down for the last 3 quarters, -30.72M → -56.64M (in $), with an average decrease of 36.2% per quarter
Organisation | Adc Therapeutics Sa |
Headquarters | BiopOle, Epalinges, Switzerland, 1066 |
Industry | Health Technology |
CEO | Dr. Ameet Mallik M.B.A., M.S. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Ms. Kimberly Pope | Senior VP & Chief People Officer |
Ms. Kristen Harrington-Smith | Chief Commercial Officer |
Dr. Ameet Mallik M.B.A., M.S. | CEO & Director |
Ms. Lisa Michelle Kallebo | Corporate Controller & Chief Accounting Officer |
Ms. Marcy Graham | Investor Relations Officer |
Dr. Patrick van Berkel Ph.D. | Chief Scientific Officer |
Mr. Peter J. Graham Esq. | Secretary & Chief Legal Officer |
Mr. Jose I. Carmona M.B.A. | Chief Financial Officer |
Dr. Mohamed Zaki M.D., Ph.D. | Chief Medical Officer |
Dr. David S. Ege Ph.D. | Chief Technical Officer |
Adc Therapeutics Sa share price today is $3.31 as on at the close of the market. Adc Therapeutics Sa share today touched a day high of $3.34 and a low of $3.16.
Adc Therapeutics Sa share touched a 52 week high of $3.97 on and a 52 week low of $1.05 on . Adc Therapeutics Sa stock price today i.e. is closed at $3.31,which is 16.62% down from its 52 week high and 215.24% up from its 52 week low.
Adc Therapeutics Sa market capitalisation is $0.00T as on .
Indian investors can start investing in Adc Therapeutics Sa (ADCT) shares with as little as ₹88.042 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Adc Therapeutics Sa stock (as per the Rupee-Dollar exchange rate as on ).
Based on Adc Therapeutics Sa share’s latest price of $3.31 as on September 17, 2025 at 1:29 am IST, you will get 3.0211 shares of Adc Therapeutics Sa. Learn more about
fractional shares .
Adc Therapeutics Sa stock has given -92.47% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?